In Vitro Invasion Assay

The gradient provides directional stimulation, encouraging cells in the upper chamber to move toward the lower chamber. This arrangement helps researchers assess whether experimental changes alter movement under a defined chemical cue. Comparing invasion with and without altered genes, signaling pathways, drugs, or microenvironmental conditions can reveal how those factors influence invasive behavior.

The matrix coating creates a barrier that more closely resembles extracellular matrix than an uncoated porous surface. Cells must move toward the chemoattractant, interact with the matrix material, and pass through membrane pores. Because the barrier adds a structural challenge, the assay can help evaluate changes in invasive capacity rather than simply measuring cell movement.

The measured number of invaded cells can vary when researchers alter gene activity, signaling pathways, drug exposure, or microenvironmental conditions. These variables may affect movement, barrier degradation, or passage through the pores. Keeping the chamber arrangement and comparison conditions consistent allows differences in the final cell counts to be linked more clearly to the factor under investigation.

Researchers place cancer cells in the upper chamber of a transwell system, with a matrix-coated porous membrane separating it from the lower chamber. A chemoattractant establishes directional stimulation, and cells that move through the barrier are subsequently stained. Researchers then count the stained invaded cells and compare those counts across experimental conditions.

After cells have passed through the matrix-coated membrane and its pores, researchers stain them so the invaded population can be identified. Counting the stained cells provides a comparative readout of invasive behavior. The resulting counts can be used to evaluate whether a gene, pathway, drug, or microenvironmental condition increases or decreases invasion under the tested conditions.

Cancer researchers use the assay to characterize metastatic potential and to examine how specific genes or signaling pathways influence invasion. It also supports evaluation of candidate anti-invasive therapies and study of microenvironmental effects. Because the system is controlled and performed in the laboratory, it complements animal and clinical studies rather than replacing those models.